Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Is persistent ketamine use a valid model of the cognitive and oculomotor deficits in schizophrenia?

Morgan CJ, Huddy V, Lipton M, Curran HV, Joyce EM.

Biol Psychiatry. 2009 Jun 15;65(12):1099-102. doi: 10.1016/j.biopsych.2008.10.045. Epub 2008 Dec 25.

2.

The relationship between antisaccades, smooth pursuit, and executive dysfunction in first-episode schizophrenia.

Hutton SB, Huddy V, Barnes TR, Robbins TW, Crawford TJ, Kennard C, Joyce EM.

Biol Psychiatry. 2004 Oct 15;56(8):553-9.

PMID:
15476684
3.

Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study.

Morgan CJ, Muetzelfeldt L, Curran HV.

Addiction. 2010 Jan;105(1):121-33. doi: 10.1111/j.1360-0443.2009.02761.x. Epub 2009 Nov 17. Erratum in: Addiction. 2010 Apr;105(4):766.

PMID:
19919593
4.

Effects of chronic ketamine use on frontal and medial temporal cognition.

Chan KW, Lee TM, Siu AM, Wong DP, Kam CM, Tsang SK, Chan CC.

Addict Behav. 2013 May;38(5):2128-32. doi: 10.1016/j.addbeh.2013.01.014. Epub 2013 Jan 31.

PMID:
23435274
5.

Smooth pursuit and saccadic abnormalities in first-episode schizophrenia.

Hutton SB, Crawford TJ, Puri BK, Duncan LJ, Chapman M, Kennard C, Barnes TR, Joyce EM.

Psychol Med. 1998 May;28(3):685-92.

PMID:
9626724
6.

The effects of ketamine and risperidone on eye movement control in healthy volunteers.

Schmechtig A, Lees J, Perkins A, Altavilla A, Craig KJ, Dawson GR, William Deakin JF, Dourish CT, Evans LH, Koychev I, Weaver K, Smallman R, Walters J, Wilkinson LS, Morris R, Williams SC, Ettinger U.

Transl Psychiatry. 2013 Dec 10;3:e334. doi: 10.1038/tp.2013.109.

7.

Neuropsychological correlates of eye movement abnormalities in schizophrenic patients and their unaffected relatives.

Zanelli J, MacCabe J, Toulopoulou T, Walshe M, McDonald C, Murray R.

Psychiatry Res. 2009 Aug 15;168(3):193-7. doi: 10.1016/j.psychres.2008.05.008. Epub 2009 Jun 21.

PMID:
19541370
8.

[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].

Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.

Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9. French.

PMID:
19081451
9.

Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls.

Morgan CJ, Muetzelfeldt L, Curran HV.

Addiction. 2009 Jan;104(1):77-87. doi: 10.1111/j.1360-0443.2008.02394.x.

PMID:
19133891
10.

Predictive pursuit association with deficits in working memory in psychosis.

Moates AF, Ivleva EI, O'Neill HB, Krishna N, Cullum CM, Thaker GK, Tamminga CA.

Biol Psychiatry. 2012 Nov 1;72(9):752-7. doi: 10.1016/j.biopsych.2012.03.030. Epub 2012 May 2.

12.

Sensorimotor transformation deficits for smooth pursuit in first-episode affective psychoses and schizophrenia.

Lencer R, Reilly JL, Harris MS, Sprenger A, Keshavan MS, Sweeney JA.

Biol Psychiatry. 2010 Feb 1;67(3):217-23. doi: 10.1016/j.biopsych.2009.08.005. Epub 2009 Sep 27.

13.

Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.

Umbricht D, Schmid L, Koller R, Vollenweider FX, Hell D, Javitt DC.

Arch Gen Psychiatry. 2000 Dec;57(12):1139-47.

PMID:
11115327
14.

Cognitive impairments in poly-drug ketamine users.

Liang HJ, Lau CG, Tang A, Chan F, Ungvari GS, Tang WK.

Addict Behav. 2013 Nov;38(11):2661-6. doi: 10.1016/j.addbeh.2013.06.017. Epub 2013 Jun 28.

PMID:
23899429
15.

Schizophrenia with obsessive-compulsive disorder and obsessive-compulsive disorder with poor insight: a neuropsychological comparison.

Tumkaya S, Karadag F, Oguzhanoglu NK, Tekkanat C, Varma G, Ozdel O, Ateşçi F.

Psychiatry Res. 2009 Jan 30;165(1-2):38-46. doi: 10.1016/j.psychres.2007.07.031. Epub 2008 Nov 7.

PMID:
18995914
16.

Eye movements and psychopathology in schizophrenia and bipolar disorder.

Tien AY, Ross DE, Pearlson G, Strauss ME.

J Nerv Ment Dis. 1996 Jun;184(6):331-8.

PMID:
8642381
17.

Cognitive impairment of executive function as a core symptom of schizophrenia.

Wobrock T, Ecker UK, Scherk H, Schneider-Axmann T, Falkai P, Gruber O.

World J Biol Psychiatry. 2009;10(4 Pt 2):442-51. doi: 10.1080/15622970701849986.

PMID:
18609418
18.

Semantic priming after ketamine acutely in healthy volunteers and following chronic self-administration in substance users.

Morgan CJ, Rossell SL, Pepper F, Smart J, Blackburn J, Brandner B, Curran HV.

Biol Psychiatry. 2006 Feb 1;59(3):265-72. Epub 2005 Sep 2.

PMID:
16140283
19.

Antisaccades and smooth pursuit eye tracking and schizotypy.

O'Driscoll GA, Lenzenweger MF, Holzman PS.

Arch Gen Psychiatry. 1998 Sep;55(9):837-43.

PMID:
9736011
20.

Relationships between neuropsychological and oculomotor measures in schizophrenia patients and normal controls.

Radant AD, Claypoole K, Wingerson DK, Cowley DS, Roy-Byrne PP.

Biol Psychiatry. 1997 Nov 1;42(9):797-805.

PMID:
9347128
Items per page

Supplemental Content

Write to the Help Desk